Login Register Cart 0
Generic placeholder image

Current Cancer Therapy Reviews

Editor-in-Chief

ISSN (Print): 1573-3947
ISSN (Online): 1875-6301

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Association between Some Helminths and Tumorigenesis through Immunological and Biochemical Factors

Author(s): Maryam Fasihi-Karami, Reza Afrisham, Saina Karami, Ehsan Beigzadeh and Forough Kazemi*

Volume 19, Issue 2, 2023

Published on: 10 November, 2022

Page: [96 - 102] Pages: 7

DOI: 10.2174/1573394718666220915114659

Price: $65

Abstract

It has been reported that more than 20% of malignancies in the developing countries are induced by some infections. However, helminth infections related to malignancies have been less appreciated. Since, helminths sometimes infect their hosts for over decades, the host’s immune responses get modulated Several studies have shown that there are many similarities between the persistence of parasite infection and the progression of tumors in terms of biochemical and immune responses. Thus, this review was designed to evaluate the association between some helminths and tumorigenesis through immunological and biochemical factors. The results of the current study showed that helminth infections could be implicated in the pathogenesis of some cancers. Several factors contribute to tumorigenesis of these helminth-stimulated tumors. These helminth infections increase the proportions of CD19+ B cells and F4/80+ macrophages as well as reduce the proportions of CD8+ lymphocytes, and increase the levels of VEGF, IL-10, and IL-4. In addition, this parasitestimulated inflammation may encourage neoplasia. Also, catechol-estrogens and oxysterols related to some helminths can play a key role in tumorigenesis. Thus, the effects of parasitic helminth infections on the development of tumor are very important. However, the investigation on these issues requires further study, which can be helpful in preventing parasitic helminth infections-related cancers.

Keywords: Helminth, Tumorigenesis, Cancer, Immunological factors, Biochemical factors

« Previous Next »
Graphical Abstract

[1]
Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144(5): 646-74.
[2]
Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009; 30(7): 1073-81.
[http://dx.doi.org/10.1093/carcin/bgp127] [PMID: 19468060]
[3]
Callejas BE, Martínez SD, Terrazas LI. Parasites as negative regulators of cancer. Biosci Rep 2018; 38(5): BSR20180935.
[http://dx.doi.org/10.1042/BSR20180935] [PMID: 30266743]
[4]
Homan EJ, Bremel RD. A role for epitope networking in immunomodulation by helminths. Front Immunol 2018; 9: 1763.
[http://dx.doi.org/10.3389/fimmu.2018.01763] [PMID: 30108588]
[5]
Herricks JR, Hotez PJ, Wanga V, et al. The global burden of disease study 2013: What does it mean for the NTDs? PLoS Negl Trop Dis 2017; 11(8): , e0005424..
[http://dx.doi.org/10.1371/journal.pntd.0005424] [PMID: 28771480]
[6]
De Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol 2012; 13(6): 607-15.
[http://dx.doi.org/10.1016/S1470-2045(12)70137-7] [PMID: 22575588]
[7]
Brindley PJ, Costa JMC, Sripa B. Why does infection with some helminths cause cancer? Trends Cancer 2015; 1(3): 174-82.
[http://dx.doi.org/10.1016/j.trecan.2015.08.011]
[8]
Consortium IHG. Comparative genomics of the major parasitic worms. Nat Genet 2019; 51(1): 163-74.
[http://dx.doi.org/10.1038/s41588-018-0262-1] [PMID: 30397333]
[9]
Ruiz MRA, Palacios AMI, Hernández CR, et al. Potential novel risk factor for breast cancer: Toxocara canis infection increases tumor size due to modulation of the tumor immune microenvironment. Front Oncol 2020; 10: 736.
[http://dx.doi.org/10.3389/fonc.2020.00736] [PMID: 32547942]
[10]
McSorley HJ, Maizels RM. Helminth infections and host immune regulation. Clin Microbiol Rev 2012; 25(4): 585-608.
[http://dx.doi.org/10.1128/CMR.05040-11] [PMID: 23034321]
[11]
Maizels RM, McSorley HJ. Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol 2016; 138(3): 666-75.
[http://dx.doi.org/10.1016/j.jaci.2016.07.007] [PMID: 27476889]
[12]
Da Costa CJM, Vale N, Gouveia MJ, et al. Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers. Front Genet 2014; 5: 444.
[http://dx.doi.org/10.3389/fgene.2014.00444] [PMID: 25566326]
[13]
Machicado C, Marcos LA. Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis: A systematic review. Int J Cancer 2016; 138(12): 2915-21.
[http://dx.doi.org/10.1002/ijc.30028] [PMID: 26840624]
[14]
Sripa B, Brindley PJ, Mulvenna J, et al. The tumorigenic liver fluke Opisthorchis viverrini – Multiple pathways to cancer. Trends Parasitol 2012; 28(10): 395-407.
[http://dx.doi.org/10.1016/j.pt.2012.07.006] [PMID: 22947297]
[15]
Honeycutt J, Hammam O, Hsieh MH. Schistosoma haematobium egg-induced bladder urothelial abnormalities dependent on p53 are modulated by host sex. Exp Parasitol 2015; 158: 55-60.
[http://dx.doi.org/10.1016/j.exppara.2015.07.002] [PMID: 26160678]
[16]
Ohnishi S, Ma N, Thanan R, Pinlaor S, Hammam O, Murata M. DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxid Med Cell Longev 2013; 2013: , 387014..
[http://dx.doi.org/10.1155/2013/]
[17]
Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med 2007; 357(10): 1018-27.
[http://dx.doi.org/10.1056/NEJMra064142] [PMID: 17804846]
[18]
Hotez PJ, Alvarado M, Basáñez MG, et al. The global burden of disease study 2010: Interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 2014; 8(7): , e2865..
[http://dx.doi.org/10.1371/journal.pntd.0002865] [PMID: 25058013]
[19]
Pullan RL, Brooker SJ. The global limits and population at risk of soil-transmitted helminth infections in 2010. Parasit Vectors 2012; 5(1): 81.
[http://dx.doi.org/10.1186/1756-3305-5-81] [PMID: 22537799]
[20]
Elliott DE, Summers RW, Weinstock JV. Helminths and the modulation of mucosal inflammation. Curr Opin Gastroenterol 2005; 21(1): 51-8.
[PMID: 15687885]
[21]
Maizels RM. Parasitic helminth infections and the control of human allergic and autoimmune disorders. Clin Microbiol Infect 2016; 22(6): 481-6.
[http://dx.doi.org/10.1016/j.cmi.2016.04.024] [PMID: 27172808]
[22]
Roach TIA, Wakelin D, Else KJ, Bundy DAP. Antigenic cross-reactivity between the human whipworm, Trichuris trichiura, and the mouse trichuroids Trichuris muris and Trichinella spiralis. Parasite Immunol 1988; 10(3): 279-91.
[http://dx.doi.org/10.1111/j.1365-3024.1988.tb00221.x] [PMID: 3412784]
[23]
Klementowicz JE, Travis MA, Grencis RK. Trichuris muris: A model of gastrointestinal parasite infection. Semin Immunopathol 2012; 34(6): 815-2.
[24]
Artis D, Potten CS, Else KJ, Finkelman FD, Grencis RK. Trichuris muris: Host intestinal epithelial cell hyperproliferation during chronic infection is regulated by interferon-γ. Exp Parasitol 1999; 92(2): 144-53.
[http://dx.doi.org/10.1006/expr.1999.4407] [PMID: 10366539]
[25]
Cliffe LJ, Humphreys NE, Lane TE, Potten CS, Booth C, Grencis RK. Accelerated intestinal epithelial cell turnover: A new mechanism of parasite expulsion. Science 2005; 308(5727): 1463-5.
[http://dx.doi.org/10.1126/science.1108661] [PMID: 15933199]
[26]
Hayes KS, Cliffe LJ, Bancroft AJ, et al. Chronic Trichuris muris infection causes neoplastic change in the intestine and exacerbates tumour formation in APC min/+ mice. PLoS Negl Trop Dis 2017; 11(6): , e0005708..
[http://dx.doi.org/10.1371/journal.pntd.0005708] [PMID: 28650985]
[27]
Rakoff NS. Why cancer and inflammation? Yale J Biol Med 2006; 79(3-4): 123-30.
[PMID: 17940622]
[28]
Dougan M, Dranoff G. Inciting inflammation: The RAGE about tumor promotion. J Exp Med 2008; 205(2): 267-70.
[http://dx.doi.org/10.1084/jem.20080136] [PMID: 18268042]
[29]
Cliffe LJ, Potten CS, Booth CE, Grencis RK. An increase in epithelial cell apoptosis is associated with chronic intestinal nematode infection. Infect Immun 2007; 75(4): 1556-64.
[http://dx.doi.org/10.1128/IAI.01375-06] [PMID: 17242061]
[30]
Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411(6835): 342-8.
[http://dx.doi.org/10.1038/35077213] [PMID: 11357141]
[31]
Bahon J, Poirriez J, Creusy C, Edriss AN, Laget JP, Dei CE. Colonic obstruction and perforation related to heavy Trichuris trichiura infestation. J Clin Pathol 1997; 50(7): 615-6.
[http://dx.doi.org/10.1136/jcp.50.7.615] [PMID: 9306948]
[32]
Botelho MC, Veiga I, Oliveira PA, Lopes C, Teixeira M, Da Costa JMC. Carcinogenic ability of Schistosoma haematobium possibly through oncogenic mutation of KRAS gene. Adv Cancer Res 2013; 201: , 876585..
[33]
Nutman TB. Looking beyond the induction of Th2 responses to explain immunomodulation by helminths. Parasite Immunol 2015; 37(6): 304-13.
[http://dx.doi.org/10.1111/pim.12194] [PMID: 25869527]
[34]
Pastille E, Frede A, McSorley HJ, et al. Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer. PLoS Pathog 2017; 13(9): , e1006649..
[http://dx.doi.org/10.1371/journal.ppat.1006649] [PMID: 28938014]
[35]
Othman AA, El-Shourbagy SH, Soliman RH. Kinetics of Foxp3-expressing regulatory cells in experimental Toxocara canis infection. Exp Parasitol 2011; 127(2): 454-9.
[http://dx.doi.org/10.1016/j.exppara.2010.10.005] [PMID: 20974133]
[36]
Khor B. Regulatory T cells: Central concepts from ontogeny to therapy. Transfus Med Rev 2017; 31(1): 36-44.
[http://dx.doi.org/10.1016/j.tmrv.2016.07.003] [PMID: 27523957]
[37]
Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8(7): 523-32.
[http://dx.doi.org/10.1038/nri2343] [PMID: 18566595]
[38]
Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141(1): 39-51.
[http://dx.doi.org/10.1016/j.cell.2010.03.014] [PMID: 20371344]
[39]
La Flamme AC, Kharkrang M, Stone S, Mirmoeini S, Chuluundorj D, Kyle R. Type II-activated murine macrophages produce IL-4. PLoS One 2012; 7(10): , e46989..
[http://dx.doi.org/10.1371/journal.pone.0046989]
[40]
Zhao X, Qu J, Sun Y, et al. Prognostic significance of tumor-associated macrophages in breast cancer: A meta-analysis of the literature. Oncotarget 2017; 8(18): 30576-86.
[http://dx.doi.org/10.18632/oncotarget.15736] [PMID: 28427165]
[41]
Alameddine RS, Otrock ZK, Awada A, Shamseddine A. Crosstalk between HER2 signaling and angiogenesis in breast cancer. Curr Opin Oncol 2013; 25(3): 313-24.
[http://dx.doi.org/10.1097/CCO.0b013e32835ff362] [PMID: 23518595]
[42]
Maizels RM. Toxocara canis: Molecular basis of immune recognition and evasion. Vet Parasitol 2013; 193(4): 365-74.
[http://dx.doi.org/10.1016/j.vetpar.2012.12.032] [PMID: 23351972]
[43]
Schnieder T, Laabs EM, Welz C. Larval development of Toxocara canis in dogs. Vet Parasitol 2011; 175(3-4): 193-206.
[http://dx.doi.org/10.1016/j.vetpar.2010.10.027] [PMID: 21095061]
[44]
Ruiz MRA, Hernández CR, Del Río AVH, Palacios AMI, Nava CKE, Morales MJ. Immune response to chronic Toxocara canis infection in a mice model. Parasite Immunol 2019; 41(12): , e12672..
[http://dx.doi.org/10.1111/pim.12672] [PMID: 31557337]
[45]
Petney TN, Andrews RH, Saijuntha W, Wenz MA, Sithithaworn P. The zoonotic, fish-borne liver flukes Clonorchis sinensis, Opisthorchis felineus and Opisthorchis viverrini. Int J Parasitol 2013; 43(12-13): 1031-46.
[http://dx.doi.org/10.1016/j.ijpara.2013.07.007] [PMID: 23978669]
[46]
Sithithaworn P, Andrews RH, Van De N, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int 2012; 61(1): 10-6.
[http://dx.doi.org/10.1016/j.parint.2011.08.014] [PMID: 21893213]
[47]
Ogorodova LM, Fedorova OS, Sripa B, et al. Opisthorchiasis: An overlooked danger. PLoS Negl Trop Dis 2015; 9(4): , e0003563..
[http://dx.doi.org/10.1371/journal.pntd.0003563] [PMID: 25836334]
[48]
Mairiang E, Laha T, Bethony JM, et al. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int 2012; 61(1): 208-11.
[http://dx.doi.org/10.1016/j.parint.2011.07.009] [PMID: 21771664]
[49]
Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8(9): 512-22.
[http://dx.doi.org/10.1038/nrgastro.2011.131] [PMID: 21808282]
[50]
IARC. IARC monographs on the evaluation of carcinogenic risks to humans. WHO. Available from https://monographs.iarc.who.int/
[51]
Thunyaharn N, Promthet S, Wiangnon S, Suwanrungruang K, Kamsa AS. Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev 2013; 14(11): 7029-32.
[http://dx.doi.org/10.7314/APJCP.2012.14.11.7029] [PMID: 24377644]
[52]
Satarug S, Haswell EMR, Sithithaworn P, et al. Relationships between the synthesis of N-nitrosodimethylamine and immune responses to chronic infection with the carcinogenic parasite, Opisthorchis viverrini, in men. Carcinogenesis 1998; 19(3): 485-91.
[http://dx.doi.org/10.1093/carcin/19.3.485] [PMID: 9525284]
[53]
Jusakul A, Loilome W, Namwat N, et al. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. Mutat Res 2012; 731(1-2): 48-57.
[http://dx.doi.org/10.1016/j.mrfmmm.2011.10.009] [PMID: 22044627]
[54]
Vale N, Gouveia MJ, Botelho M, et al. Carcinogenic liver fluke Opisthorchis viverrini oxysterols detected by LC–MS/MS survey of soluble fraction parasite extract. Parasitol Int 2013; 62(6): 535-42.
[http://dx.doi.org/10.1016/j.parint.2013.08.001] [PMID: 23973383]
[55]
Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354(3): 270-82.
[http://dx.doi.org/10.1056/NEJMra050776] [PMID: 16421368]
[56]
Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344(4): 276-85.
[http://dx.doi.org/10.1056/NEJM200101253440407] [PMID: 11172156]
[57]
Cavalieri E, Rogan E. The molecular etiology and prevention of estrogen-initiated cancers. Mol Aspects Med 2014; 36: 1-55.
[http://dx.doi.org/10.1016/j.mam.2013.08.002] [PMID: 23994691]
[58]
Cavalieri EL, Rogan EG. Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer. J Steroid Biochem Mol Biol 2011; 125(3-5): 169-80.
[http://dx.doi.org/10.1016/j.jsbmb.2011.03.008] [PMID: 21397019]
[59]
Kuver R. Mechanisms of oxysterol-induced disease: Insights from the biliary system. Clin Lipidol 2012; 7(5): 537-48.
[http://dx.doi.org/10.2217/clp.12.53] [PMID: 23630545]
[60]
Jusakul A, Yongvanit P, Loilome W, Namwat N, Kuver R. Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis 2011; 10(1): 44.
[http://dx.doi.org/10.1186/1476-511X-10-44] [PMID: 21388551]
[61]
Holtfreter MC, Moné H, Müller SI, Mouahid G, Richter J. Schistosoma haematobium infections acquired in Corsica, France, August 2013. Euro Surveill 2014; 19(22): 20821.
[http://dx.doi.org/10.2807/1560-7917.ES2014.19.22.20821] [PMID: 24925456]
[62]
Honeycutt J, Hammam O, Fu CL, Hsieh MH. Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer. Trends Parasitol 2014; 30(7): 324-32.
[http://dx.doi.org/10.1016/j.pt.2014.05.004] [PMID: 24913983]
[63]
Zhong X, Isharwal S, Naples JM, et al. Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection. PLoS One 2013; 8(3): , e59089..
[http://dx.doi.org/10.1371/journal.pone.0059089] [PMID: 23527093]
[64]
Botelho M, Ferreira AC, Oliveira MJ, Domingues A, Machado JC, Da Costa JMC. Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells. Int J Parasitol 2009; 39(10): 1083-91.
[http://dx.doi.org/10.1016/j.ijpara.2009.02.016] [PMID: 19285502]
[65]
Botelho MC, Crespo M, Almeida A, et al. Schistosoma haematobium and Schistosomiasis mansoni: Production of an estradiol-related compound detected by elisa. Exp Parasitol 2009; 122(3): 250-3.
[http://dx.doi.org/10.1016/j.exppara.2009.04.001] [PMID: 19361503]
[66]
Botelho MC, Machado JC, Brindley PJ, Da Costa CJM. Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer. Virulence 2011; 2(4): 267-79.
[http://dx.doi.org/10.4161/viru.2.4.16734] [PMID: 21788729]
[67]
Botelho MC, Oliveira PA, Lopes C, Da Costa JMC, Machado JC. Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium. Urol Oncol 2011; 29(6): 809-14.
[68]
Botelho MC, Soares R, Vale N, et al. Schistosoma haematobium: Identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells. Exp Parasitol 2010; 126(4): 526-35.
[http://dx.doi.org/10.1016/j.exppara.2010.06.012] [PMID: 20547157]
[69]
Botelho MC, Vale N, Gouveia MJ, et al. Tumour-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosoma haematobium: An oestrogen–DNA adducts mediated pathway? Int J Parasitol 2013; 43(1): 17-26.
[http://dx.doi.org/10.1016/j.ijpara.2012.10.023] [PMID: 23260770]
[70]
Young ND, Jex AR, Li B, et al. Whole-genome sequence of Schistosoma haematobium. Nat Genet 2012; 44(2): 221-5.
[http://dx.doi.org/10.1038/ng.1065] [PMID: 22246508]
[71]
Gouveia MJ, Santos J, Brindley PJ, et al. Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer. Cancer Lett 2015; 359(2): 226-32.
[http://dx.doi.org/10.1016/j.canlet.2015.01.018] [PMID: 25615421]
[72]
Gouveia MJ, Brindley PJ, Santos LL, Da Costa CJM, Gomes P, Vale N. Mass spectrometry techniques in the survey of steroid metabolites as potential disease biomarkers: A review. Metabolism 2013; 62(9): 1206-17.
[http://dx.doi.org/10.1016/j.metabol.2013.04.003] [PMID: 23664145]
[73]
Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118(12): 3030-44.
[http://dx.doi.org/10.1002/ijc.21731] [PMID: 16404738]
[74]
Catalano C, Aron J, Bansal R, Leytin A. Colorectal cancer associated with Strongyloides stercoralis colitis. ACG Case Rep J 2017; 4(1): , e104..
[http://dx.doi.org/10.14309/crj.2017.104] [PMID: 28879209]
[75]
Sava M, Huynh T, Frugoli A, Kong L, Salehpour M, Barrows B. Colorectal cancer related to chronic Strongyloides stercoralis infection. Case Rep Gastroenterol 2020; 2020: , 8886460..
[http://dx.doi.org/10.1155/2020/8886460]
[76]
Greaves D, Coggle S, Pollard C, Aliyu SH, Moore EM. Strongyloides stercoralis infection BMJ 2013; 347(jul30 3):: f4610.. http://dx.doi.org/10.1136/bmj.f4610 PMID: 23900531
[77]
Knoll LJ, Hogan DA, Leong JM, Heitman J, Condit RC. Pearls collections: what we can learn about infectious disease and cancer. PLoS Pathog 2018; 14(3): , e1006915..
[78]
Vennervald BJ, Polman K. Helminths and malignancy. Parasite Immunol 2009; 31(11): 686-96.
[http://dx.doi.org/10.1111/j.1365-3024.2009.01163.x] [PMID: 19825108]
[79]
Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KVI. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 2004; 100(7): 1531-6.
[http://dx.doi.org/10.1002/cncr.20120]
[80]
Tanaka T, Hirata T, Parrott G, et al. Relationship among Strongyloides stercoralis infection, human T-cell lymphotropic virus type 1 infection, and cancer: A 24-year cohort inpatient study in Okinawa, Japan. Am J Trop Med Hyg 2016; 94(2): 365-70.
[http://dx.doi.org/10.4269/ajtmh.15-0556] [PMID: 26621566]
[81]
Seo AN, Goo YK, Chung DI, Hong Y, Kwon O, Bae HI. Comorbid gastric adenocarcinoma and gastric and duodenal Strongyloides stercoralis infection: A case report. Korean J Parasitol 2015; 53(1): 95-9.
[http://dx.doi.org/10.3347/kjp.2015.53.1.95] [PMID: 25748714]
[82]
Satoh M, Toma H, Sugahara K, et al. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4+25+ HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis. Oncogene 2002; 21(16): 2466-75.
[http://dx.doi.org/10.1038/sj.onc.1205329] [PMID: 11971181]
[83]
Tomaino C, Catalano C, Tiba M, Aron J. Su2012 a first case report of colorectal cancer associated with chronic Strongyloides stercoralis colitis and the complex management decisions that follow. Gastroenterology 2015; 148(4): S-575.
[http://dx.doi.org/10.1016/S0016-5085(15)31941-7]
[84]
Sohn WM, Yong TS, Eom KS, et al. Prevalence of Haplorchis taichui among humans and fish in Luang Prabang Province, Lao PDR. Acta Trop 2014; 136: 74-80.
[http://dx.doi.org/10.1016/j.actatropica.2014.04.020] [PMID: 24754919]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy